The clinivation Global xi enterprise solution for Market Clearance Management enables executives and their teams to address the challenges of execution, effective governance, and lean business performance in their global market clearance operations. By enabling excellence in global market clearance operations to advance the revenue intrinsic to market clearance success, clinivation Global xi liberates revenue that's trapped-in-process.

Headquartered in Arlington, Tennessee, with over 50 years of experience, Wright Medical Technology, Inc. is a global provider of specialized orthopedic medical devices. The company designs, manufactures, and markets an array of reconstructive joint devices and biologics that assists in mobility, bone function, and faster surgical recovery. From large joint implants and extremity implants to bone graft materials and soft tissue repair, Wright Medical continues to improve patient's lives through orthopedic innovation and new product development. For instance, the company offers CONSERVE® BHF® Hip, ADVANCE® Medial-Pivot Knee, and INBONE™ Total Ankle Arthoplasty for total hip, knee and, ankle replacement respectively. It also offers GRAFTJACKET® Matrix for soft tissue repair of the shoulder, Achilles tendon, hand, foot, and hip. To facilitate in bone re-growth, the company offers an advanced composite product called PRO-DENSE® Injectable Regenerative Graft.

For more information, please visit www.wmt.com.

Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.

Used in over 1,000,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.

The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.

Our core brands include the clinivation Global^® xi market clearance platform, clinivation WorldView^® on-demand regulatory intelligence, and clinivation Clinical Suite^® and clinivation Registry Suite^® electronic data capture and clinical data management software.

Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.

Visit clinivation online at www.clinivation.com

For more information on clinivation's integrated solutions that enable global market clearance, please click here or call us at 508.655.6560.